Ticker >

Vivanza Biosciences share price

Vivanza Biosciences Ltd.

BSE: 530057 SECTOR: Trading  6939   8   0

8.12
+0.09 (1.12%)
BSE: Today, 09:53 AM

Price Summary

Today's High

₹ 8.3

Today's Low

₹ 8

52 Week High

₹ 16.13

52 Week Low

₹ 5.7

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

32.48 Cr.

Enterprise Value

38.94 Cr.

No. of Shares

4 Cr.

P/E

50.91

P/B

6.38

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  1.27

CASH

0.1 Cr.

DEBT

6.56 Cr.

Promoter Holding

43.24 %

EPS (TTM)

₹  0.16

Sales Growth

55.31%

ROE

13.84 %

ROCE

11.66%

Profit Growth

22.73 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year55.31%
3 Year14.9%
5 Year17.14%

Profit Growth

1 Year22.73%
3 Year68.61%
5 Year18.85%

ROE%

1 Year13.84%
3 Year9.91%
5 Year2.31%

ROCE %

1 Year11.66%
3 Year14.89%
5 Year10.02%

Debt/Equity

1.4926

Price to Cash Flow

202.12

Interest Cover Ratio

2.58670053105518

CFO/PAT (5 Yr. Avg.)

1.19167780407415

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 43.24 0
Dec 2023 44.9 0
Sep 2023 47.29 0
Jun 2023 47.8 0
Mar 2023 47.8 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has a good cash flow management; CFO/PAT stands at 1.19167780407415.

 Limitations

  • The company has shown a poor revenue growth of 14.8966546340397% for the Past 3 years.
  • Company has high debtor days of 250.941353679824.
  • The company has a low EBITDA margin of 0.602085091017104% over the past 5 years.
  • The company is trading at a high PE of 50.91.
  • The company is trading at a high EV/EBITDA of 30.016.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 4.8 6.02 4.88 3.87 3.37
Total Expenditure 4.28 5.98 4.45 3.63 3.1
Operating Profit 0.52 0.04 0.42 0.24 0.27
Other Income 0.01 0.12 0.01 0.05 0.02
Interest 0.11 0.11 0.11 0.11 0.1
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.42 0.06 0.33 0.19 0.18
Tax 0 0.12 0 0 0
Profit After Tax 0.42 -0.06 0.33 0.19 0.18
Adjusted EPS (Rs) 0.1 -0.01 0.08 0.05 0.05

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 2.22 9.37 9.22 9.15 14.21
Total Expenditure 2.25 9.66 9.09 9.07 13.47
Operating Profit -0.03 -0.3 0.13 0.07 0.74
Other Income 0 0.53 0.5 0.83 0.39
Interest 0.42 0.44 0.47 0.43 0.43
Depreciation 0 0 0.01 0.01 0
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.45 -0.2 0.15 0.46 0.69
Tax 0 0 0.05 0 0.12
Net Profit -0.45 -0.2 0.1 0.46 0.57
Adjusted EPS (Rs.) -0.11 -0.05 0.03 0.12 0.14

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 4 4 4 4 4
Total Reserves -0.53 -0.73 -0.63 -0.17 0.4
Borrowings 0 0 0 0 0
Other N/C liabilities 0 0 0 0 0
Current liabilities 7.36 9.01 4.57 10.38 16.04
Total Liabilities 10.83 12.28 7.93 14.21 20.44
Assets
Net Block 0 0 0.01 0 0
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 1.91 1.91 1.91 1.91 1.91
Loans & Advances 0.59 0.59 0.59 0.59 0.59
Other N/C Assets 0 0 0 0 0
Current Assets 8.32 9.77 5.41 11.7 17.93
Total Assets 10.83 12.28 7.93 14.21 20.44
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations -0.45 -0.2 0.15 0.46 0.69
Adjustment 0.43 0.44 0.48 0.41 0.42
Changes in Assets & Liabilities 1.39 2.56 -3.65 -1.55 -0.83
Tax Paid 0 0 -0.05 0 -0.12
Operating Cash Flow 1.37 2.8 -3.08 -0.68 0.16
Investing Cash Flow 0 0 -0.02 0 0
Financing Cash Flow -1.38 -2.58 2.8 0.65 -0.08
Net Cash Flow -0.01 0.22 -0.3 -0.03 0.09

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 47.80 47.80 47.29 44.90 43.24
hemant amrish parikh 2.75 2.75 2.24 1.91 0.25
parth hemant parikh 45.05 45.05 45.05 42.99 42.99
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 52.20 52.20 52.71 55.10 56.76
ardent ventures llp 23.76 23.76 23.76 23.76 23.09
ashoka metcast ltd 22.61 22.61 22.54 21.93 19.37

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Vivanza Biosciences informs about non-applicability of statement of deviation or variation 11 Apr 2024, 4:17PM Vivanza Biosciences informs about disclosure26 Feb 2024, 3:11PM Vivanza Biosciences informs about disclosures 23 Feb 2024, 12:32PM Vivanza Biosciences informs about disclosure22 Feb 2024, 2:20PM Vivanza Biosciences informs about disclosure22 Feb 2024, 2:20PM Vivanza Biosciences - Quaterly Results6 Feb 2024, 4:26PM Vivanza Biosciences - Quaterly Results6 Feb 2024, 4:26PM Vivanza Biosciences - Quaterly Results6 Feb 2024, 4:26PM Vivanza Biosciences informs about disclosure4 Jan 2024, 9:46AM Vivanza Biosciences informs about disclosure7 Dec 2023, 2:38PM Vivanza Biosciences informs about disclosures 4 Nov 2023, 2:45PM Vivanza Biosciences - Quaterly Results26 Oct 2023, 4:33PM Vivanza Biosciences - Quaterly Results26 Oct 2023, 4:33PM Vivanza Biosciences - Quaterly Results26 Oct 2023, 4:33PM Vivanza Biosciences informs about compliances-certificate17 Oct 2023, 5:08PM Vivanza Biosciences informs about outcome of board meeting1 Sep 2023, 3:42PM Vivanza Biosciences informs about AGM26 Jul 2023, 1:23PM Vivanza Biosciences informs about outcome of Board Meeting 1 Jul 2023, 2:13PM Vivanza Biosciences informs about board meeting outcome1 Jul 2023, 12:26PM Vivanza Biosciences informs about press release27 Apr 2023, 3:23PM Vivanza Biosciences - Quaterly Results25 Apr 2023, 7:08PM Vivanza Biosciences - Quaterly Results25 Apr 2023, 7:08PM Vivanza Biosciences informs about outcome of board meeting4 Mar 2023, 12:54PM Vivanza Biosciences informs about scrutinizer report on e-voting 25 Feb 2023, 2:36PM Vivanza Biosciences informs about board meeting25 Feb 2023, 11:47AM Vivanza Biosciences informs about newspaper advertisement25 Jan 2023, 4:35PM Vivanza Biosciences - Quaterly Results24 Jan 2023, 4:30PM Vivanza Biosciences - Quaterly Results24 Jan 2023, 4:30PM Vivanza Biosciences - Quaterly Results24 Jan 2023, 4:30PM Vivanza Biosciences informs about confirmation certificate6 Jan 2023, 12:31PM Vivanza Biosciences informs about disclosure15 Nov 2022, 3:37PM Vivanza Biosciences informs about board meeting intimation 5 Nov 2022, 3:09PM Vivanza Biosciences informs about compliances-certificate6 Oct 2022, 4:10PM Vivanza Biosciences informs about newspaper publication22 Jul 2022, 1:33PM Vivanza Biosciences - Quaterly Results21 Jul 2022, 1:08PM Vivanza Biosciences - Quaterly Results21 Jul 2022, 1:08PM Vivanza Biosciences - Quaterly Results21 Jul 2022, 1:08PM Vivanza Biosciences informs about compliance certificate11 Jul 2022, 3:37PM Vivanza Biosciences informs about certificate30 Apr 2022, 3:28PM Vivanza Biosciences - Quaterly Results10 Feb 2022, 6:58PM Vivanza Biosciences informs about independent directors meet16 Mar 2021, 4:22PM Vivanza Biosciences informs about compliance certificate26 Oct 2020, 4:38PM

Vivanza Biosciences Stock Price Analysis and Quick Research Report. Is Vivanza Biosciences an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Vivanza Biosciences has a PE ratio of 50.9090909090909 which is high and comparatively overvalued .

  • Share Price: - The current share price of Vivanza Biosciences is Rs 8.12. One can use valuation calculators of ticker to know if Vivanza Biosciences share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Vivanza Biosciences has ROA of 3.28507602258165 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Vivanza Biosciences has a Current ratio of 1.11767345895641 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Vivanza Biosciences has a ROE of 13.8354382680783 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Vivanza Biosciences has a D/E ratio of 1.4926 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Vivanza Biosciences has an Inventory turnover ratio of 7.40807174887892 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Vivanza Biosciences has reported revenue growth of 55.312380431812 % which is fair in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Vivanza Biosciences for the current financial year is 5.1804718734163 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Vivanza Biosciences is Rs 0 and the yield is 0 %.

Last Updated on:
Brief about Vivanza Biosciences
X